These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 9388532)
1. Physiological "constants" for PBPK models for pregnancy. Young JF; Branham WS; Sheehan DM; Baker ME; Wosilait WD; Luecke RH J Toxicol Environ Health; 1997 Dec; 52(5):385-401. PubMed ID: 9388532 [TBL] [Abstract][Full Text] [Related]
2. A physiologically based pharmacokinetic computer model for human pregnancy. Luecke RH; Wosilait WD; Pearce BA; Young JF Teratology; 1994 Feb; 49(2):90-103. PubMed ID: 8016750 [TBL] [Abstract][Full Text] [Related]
3. Mathematical modeling of human embryonic and fetal growth rates. Luecke RH; Wosilait WD; Young JF Growth Dev Aging; 1999; 63(1-2):49-59. PubMed ID: 10885857 [TBL] [Abstract][Full Text] [Related]
4. Expression of cyclooxygenase-2 in embryonic and fetal tissues during organogenesis and late pregnancy. Stanfield KM; Bell RR; Lisowski AR; English ML; Saldeen SS; Khan KN Birth Defects Res A Clin Mol Teratol; 2003 Jan; 67(1):54-8. PubMed ID: 12749384 [TBL] [Abstract][Full Text] [Related]
5. Development of a physiologically based pharmacokinetic model describing 2-methoxyacetic acid disposition in the pregnant mouse. Terry KK; Elswick BA; Welsch F; Conolly RB Toxicol Appl Pharmacol; 1995 May; 132(1):103-14. PubMed ID: 7747273 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of 2-methoxyethanol and 2-methoxyacetic acid in the pregnant mouse: a physiologically based mathematical model. Clarke DO; Elswick BA; Welsch F; Conolly RB Toxicol Appl Pharmacol; 1993 Aug; 121(2):239-52. PubMed ID: 8346541 [TBL] [Abstract][Full Text] [Related]
7. Gestational age dependency in the prenatal toxicity and in the disposition kinetics of the novel anticonvulsant HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) after subcutaneous administration in pregnant rats. Gómez-Martínez LE Int J Toxicol; 2007; 26(3):237-46. PubMed ID: 17564905 [TBL] [Abstract][Full Text] [Related]
8. Development of a physiologically based pharmacokinetic model for bisphenol A in pregnant mice. Kawamoto Y; Matsuyama W; Wada M; Hishikawa J; Chan MP; Nakayama A; Morisawa S Toxicol Appl Pharmacol; 2007 Oct; 224(2):182-91. PubMed ID: 17698157 [TBL] [Abstract][Full Text] [Related]
9. Significance of pharmacokinetic variables in reproductive and developmental toxicity. Neubert D Xenobiotica; 1988 Jan; 18 Suppl 1():45-58. PubMed ID: 3278490 [TBL] [Abstract][Full Text] [Related]
10. Physiologically based pharmacokinetic modeling of fetal and neonatal manganese exposure in humans: describing manganese homeostasis during development. Yoon M; Schroeter JD; Nong A; Taylor MD; Dorman DC; Andersen ME; Clewell HJ Toxicol Sci; 2011 Aug; 122(2):297-316. PubMed ID: 21622944 [TBL] [Abstract][Full Text] [Related]
11. Predicting fetal perchlorate dose and inhibition of iodide kinetics during gestation: a physiologically-based pharmacokinetic analysis of perchlorate and iodide kinetics in the rat. Clewell RA; Merrill EA; Yu KO; Mahle DA; Sterner TR; Mattie DR; Robinson PJ; Fisher JW; Gearhart JM Toxicol Sci; 2003 Jun; 73(2):235-55. PubMed ID: 12700398 [TBL] [Abstract][Full Text] [Related]
12. Physiologically based pharmacokinetics of methoxyacetic acid: dose-effect considerations in C57BL/6 mice. O'Flaherty EJ; Nau H; McCandless D; Beliles RP; Schreiner CM; Scott WJ Teratology; 1995 Aug; 52(2):78-89. PubMed ID: 8588185 [TBL] [Abstract][Full Text] [Related]
14. Evaluating placental transfer and tissue concentrations of manganese in the pregnant rat and fetuses after inhalation exposures with a PBPK model. Yoon M; Nong A; Clewell HJ; Taylor MD; Dorman DC; Andersen ME Toxicol Sci; 2009 Nov; 112(1):44-58. PubMed ID: 19726578 [TBL] [Abstract][Full Text] [Related]
15. Development of a physiologically based pharmacokinetic model of 2-methoxyethanol and 2-methoxyacetic acid disposition in pregnant rats. Hays SM; Elswick BA; Blumenthal GM; Welsch F; Conolly RB; Gargas ML Toxicol Appl Pharmacol; 2000 Feb; 163(1):67-74. PubMed ID: 10662606 [TBL] [Abstract][Full Text] [Related]
16. Timing of gestation in rats by fetal and maternal weights. Knox WE; Lister-Rosenoer LM Growth; 1978 Mar; 42(1):43-53. PubMed ID: 566694 [TBL] [Abstract][Full Text] [Related]
17. Critical period for a teratogenic VLA-4 antagonist: Developmental effects and comparison of embryo drug concentrations of teratogenic and non-teratogenic VLA-4 antagonists. Crofts F; Rohatagi S; Pino M; DeLise B; Zhang J; Nguyen M; Guittin P; Barbellion S; Brunel P; Hofmann T; Schmidt J; Wong M; Lockey P; Lerman S; Clark R Birth Defects Res B Dev Reprod Toxicol; 2004 Apr; 71(2):69-79. PubMed ID: 15098200 [TBL] [Abstract][Full Text] [Related]
18. Tissue exposures to free and glucuronidated monobutylyphthalate in the pregnant and fetal rat following exposure to di-n-butylphthalate: evaluation with a PBPK model. Clewell RA; Kremer JJ; Williams CC; Campbell JL; Andersen ME; Borghoff SJ Toxicol Sci; 2008 Jun; 103(2):241-59. PubMed ID: 18344531 [TBL] [Abstract][Full Text] [Related]
19. Metabolism and pharmacokinetics of bisphenol A (BPA) and the embryo-fetal distribution of BPA and BPA-monoglucuronide in CD Sprague-Dawley rats at three gestational stages. Domoradzki JY; Pottenger LH; Thornton CM; Hansen SC; Card TL; Markham DA; Dryzga MD; Shiotsuka RN; Waechter JM Toxicol Sci; 2003 Nov; 76(1):21-34. PubMed ID: 12915710 [TBL] [Abstract][Full Text] [Related]